• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Apple to Sell One Drop’s Blood Glucose Monitors in Select Retail Stores

by Fred Pennic 06/27/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Apple to Sell One Drop’s Blood Glucose Monitors in Select Retail Stores

One Drop, a digital blood glucose monitoring kit for diabetes management will now be available in select retail Apple stores, CNBC reports. Currently sold online in the Apple Store for $69.95, the digital diabetes kit includes a Bluetooth glucose meter, test strips, lancets (optional), and one year of free coaching from a certified diabetes coach.

One Drop Blood Glucose Monitor

One Drop’s blood glucose meter ensures clinically proven accurate, reliable results in just five seconds. The meter then wirelessly transmits that blood glucose data via Bluetooth to the One Drop Mobile app on your iOS device. Exceeding all FDA and CE requirements, the meter is compatible with the iPhone, Apple Watch, iPad, and iPod touch. Through the app, it lets you track everything in one place: blood glucose, food, medication, and activity.

The company recently expanded its AI-powered Predictive Insights to include 8-hour blood glucose forecasts for One Drop | Mobile iOS users with type 2 diabetes, including those on oral medications and/or basal insulin regimens, making One Drop the only provider of blood glucose forecasts for people with type 2 diabetes. Additionally, the One Drop app offers an easy-to-use Personal Health Assistant — a digital tool for monitoring medication, food and physical activity as well as blood sugar, blood pressure, weight, and other health markers.

Financial Impact of Diabetes in the U.S.

In the USA, 1 in 11 people has diabetes, costing the healthcare system more than $150 billion annually. For these individuals, maintaining blood glucose in the normal range (80–180 mg/dL) is a critical part of reducing emergency department visits, hospitalizations, renal failure and other costly complications of diabetes.

“The healthcare industry is deeply invested in resisting progress, but consumerized, data-driven, digital health is becoming a reality,” said Jeff Dachis, One Drop Founder and CEO. “Diabetes affects more than 30 million Americans today, many of whom face a tremendous amount of stigma and lack of adequate support from an over-burdened system. One Drop is shifting value towards the consumer, while remaining relentlessly focused on improving outcomes and quality of life.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, apple, Apple Watch, Blood Glucose Monitor, Blood Pressure, Bluetooth, diabetes, Diabetes Management, Diabetes Management Platform, digital diabetes management platform, digital health, FDA, glucose data, insulin, medication, One Drop, personal health assistant, Type 2 Diabetes

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |